Cellectis (CLLS) Other Non Operating Income (2021 - 2025)
Cellectis' (CLLS) quarterly Other Non Operating Income came in at $1.1 billion in Q3 2025, up 112.14% year-on-year from $540.2 million in Q3 2024, and up 399203.14% quarter-over-quarter from $287000.0 in Q2 2025.
Cellectis (CLLS) Other Non Operating Income (2021 - 2025) Analysis & Trends
Cellectis' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $1.1 billion for Q3 2025.
- On a quarterly basis, Other Non Operating Income rose 112.14% year-over-year to $1.1 billion in Q3 2025; TTM through Sep 2025 was -$8.3 billion, a 12.15% increase from a year earlier, with the FY2021 full-year figure at $1.5 million, changed N/A from the prior year.
- Other Non Operating Income improved to $1.1 billion in Q3 2025 per CLLS's latest filing, from $287000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.1 billion in Q3 2025 and bottomed at -$9.4 billion in Q3 2024.
- The 5-year median for Other Non Operating Income is $62500.0 (2023), against an average of -$518.2 million.
- Across the five-year window, Other Non Operating Income sank 5826643.21% in 2024 and soared 856.67% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $3.5 million in 2021, then tumbled by 105.97% to -$210000.0 in 2022, then surged by 177.14% to $162000.0 in 2023, then sank by 5826643.21% to -$9.4 billion in 2024, then soared by 112.14% to $1.1 billion in 2025.
- Per Business Quant, the three latest CLLS Other Non Operating Income figures stand at $1.1 billion (Q3 2025), $287000.0 (Q2 2025), and $750000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Cellectis | 285.50 Mn | 99.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.15 Bn |
| Jun 30, 2025 | 287,000.00 |
| Mar 31, 2025 | 750,000.00 |
| Sep 30, 2024 | -9.44 Bn |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 95,000.00 |
| Mar 31, 2023 | -80,000.00 |
| Sep 30, 2022 | -210,000.00 |
| Jun 30, 2022 | -255,000.00 |
| Mar 31, 2022 | -126,000.00 |
| Dec 31, 2021 | 3.52 Mn |
| Sep 30, 2021 | 12.92 Mn |
| Jun 30, 2021 | -15.05 Mn |
| Mar 31, 2021 | 141,000.00 |